Repligen Will Report Third Quarter Financial Results Soon

Waltham-based Repligen Corporation is set to release its Q3 2026 financial performance on October 27, 2026.

Updated on Oct. 13, 2026 in Public Companies

Bold flat-color editorial illustration in navy and cream, showing a simplified geometric laboratory building, representing institutional financial reporting.
Repligen Corporation will announce its third-quarter 2026 financial results on October 27, providing an update on the Waltham-based company's performance. AI Illustration. Upload story photo >

Repligen Corporation will announce its third quarter 2026 financial results on October 27, 2026. A press release detailing the performance for the period ending September 30, 2026, will be issued before the market opens.

Why it matters

The upcoming report provides investors with an updated look at the financial health of the Waltham-based firm. The associated conference call will offer further insight into business updates following the close of the third quarter.

The conference call meeting ID is 877042431. This event marks the official conclusion of the company's third quarter reporting period which ended on September 30, 2026.

The players

Repligen Corporation

Repligen Corporation is a life sciences company headquartered in Waltham, Massachusetts, that focuses on the development and commercialization of bioprocessing technologies.

The details

Repligen Corporation will host a conference call at 8:00 a.m. ET to discuss the financial results and provide business updates. Stakeholders can access the call via a webcast on the company website or by dialing (833) 461-5787 for domestic callers and (585) 542-9983 for international callers.

Timeline

  1. September 30, 2026: The third quarter financial reporting period concludes.

  2. October 27, 2026: The company reports financial results and hosts a conference call at 8:00 a.m. ET.

Market Landscape

This earnings release follows the standard quarterly earnings reporting cycle for publicly traded companies. It positions the firm to demonstrate its operational progress against competitors within the broader life sciences sector.

Investors and stakeholders can monitor the company website for the upcoming press release and webcast details. The event serves as a primary opportunity to review the firm's financial status and future business outlook.

The takeaway

Shareholders should mark their calendars for the morning of October 27 to review the latest financial data. Accessing the official company webcast is the most efficient way to follow the management discussion.

What happens next

Repligen Corporation will issue a press release and hold a conference call on October 27, 2026, at 8:00 a.m. ET.

Further reading

Learn more about local business performance in the Public Companies section.